Fortis Healthcare share news, announcements and annual reports
NSE: FORTISBSE: 532843Healthcare ServicesMid Cap
Fortis Healthcare Limited · Formerly Fortis Healthcare (India) · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2007
Last close ₹768.15up ₹13.25 (1.76%)BSE ₹769.80
Share price at the NSE close on 30 Oct 2026. Previous close ₹754.90.
30 Oct: open ₹754.90, high ₹768.15, low ₹745.00
52-week range of traded prices to 30 Oct 2026
₹704.95Low, 23 Oct 2026₹1,057.45High, 30 Oct 2025
- Next results date: the board meets on 5 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹57,992 Cr156th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 55.34
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.86
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.13%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.28
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 14,56,10356.9% delivered
Fortis Healthcare shareholding disclosures
112 filed, newest first. Page 2 of 3.
Apr 2013
Mar 2013
Feb 2013
Dec 2012
Nov 2012
Oct 2012
Sep 2012
Aug 2012
Jul 2012
Jun 2012
May 2012
Apr 2012
Mar 2012
Feb 2012
23 Feb · Disclosure
In terms of "Employee Stock Option Plan - 2011", the Human Resources & Remuneration Committee of the Company has on February 23, 2012, approved granting of 4,050,000 (Forty Lacs Fifty Thousand) Stock Options, on the following terms: (1) No. of Shares covered : 4,050,000 Equity Shares , (2) Vesting Period : The total award will be vested on the third anniversary of the grant date. (3) Exercise Price : Rs. 111.00, (4) Maximum Exercise Period : The Exercise Period will commence from the vesting date and extend up to the expiry date which shall be second anniversary of the vesting date. The granting, vesting and exercise of the Options is subject to necessary regulatory and statutory approvals.
Jan 2012
Dec 2011